Published in Virology on March 23, 2007
West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol (2008) 1.75
Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J Virol (2007) 1.38
West Nile virus. Clin Lab Med (2010) 1.10
Virulence determinants between New York 99 and Kunjin strains of West Nile virus. Virology (2011) 1.04
Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain. Vaccine (2011) 0.95
West Nile virus: A re-emerging pathogen revisited. World J Virol (2012) 0.94
Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity. Virology (2008) 0.92
Identification of inhibitors of yellow fever virus replication using a replicon-based high-throughput assay. Antimicrob Agents Chemother (2009) 0.88
Programmed ribosomal frameshift alters expression of west nile virus genes and facilitates virus replication in birds and mosquitoes. PLoS Pathog (2014) 0.86
West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon response. J Gen Virol (2012) 0.84
Oxidative stress influences positive strand RNA virus genome synthesis and capping. Virology (2014) 0.83
Flavitrack analysis of the structure and function of West Nile non-structural proteins. Int J Bioinform Res Appl (2010) 0.80
Reconciling West Nile virus with the autophagic pathway. Autophagy (2015) 0.79
Structural gene (prME) chimeras of St Louis encephalitis virus and West Nile virus exhibit altered in vitro cytopathic and growth phenotypes. J Gen Virol (2011) 0.78
In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model. Viruses (2016) 0.76
Clinical outcome and genetic differences within a monophyletic Dengue virus type 2 population. PLoS One (2015) 0.76
A Single Amino Acid Substitution in the NS2A Protein of Japanese Encephalitis Virus Affects Virus Propagation In Vitro but Not In Vivo. J Virol (2015) 0.75
RNA interference screen for human genes associated with West Nile virus infection. Nature (2008) 4.93
West Nile virus: where are we now? Lancet Infect Dis (2004) 3.49
Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci U S A (2012) 2.59
Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol (2006) 2.57
The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol (2010) 1.94
Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology (2010) 1.92
West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol (2007) 1.86
PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrob Agents Chemother (2010) 1.84
West Nile virus replication interferes with both poly(I:C)-induced interferon gene transcription and response to interferon treatment. Virology (2005) 1.59
trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J Virol (2004) 1.57
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations. J Biol Chem (2005) 1.54
Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis. Vaccine (2008) 1.54
West Nile virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR. J Virol (2007) 1.54
Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology (2006) 1.49
Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J Virol (2007) 1.48
Use of complementary and alternative medicine for the treatment of genital herpes. Herpes (2005) 1.48
Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action. Virology (2005) 1.48
Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med (2013) 1.47
Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J Virol (2007) 1.38
High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides. Sex Transm Dis (2009) 1.38
Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661. Antiviral Res (2011) 1.35
Role of nonstructural proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus. J Virol (2003) 1.27
miR-122 does not modulate the elongation phase of hepatitis C virus RNA synthesis in isolated replicase complexes. Antiviral Res (2010) 1.25
Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine. J Infect Dis (2004) 1.25
Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes. Vector Borne Zoonotic Dis (2010) 1.23
Salivary gland morphology and virus transmission during long-term cytopathologic West Nile virus infection in Culex mosquitoes. Am J Trop Med Hyg (2007) 1.19
Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents. Sex Transm Dis (2002) 1.15
The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3). J Biol Chem (2013) 1.14
Application of optical coherence tomography for monitoring changes in cervicovaginal epithelial morphology in macaques: potential for assessment of microbicide safety. Sex Transm Dis (2008) 1.13
Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. J Infect Dis (2003) 1.13
Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines. Virology (2006) 1.10
Production of pseudoinfectious yellow fever virus with a two-component genome. J Virol (2007) 1.09
Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system. Vaccine (2008) 1.09
RNA-based vaccines. Vaccine (2012) 1.08
Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors. Gastroenterology (2008) 1.07
Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses. Antimicrob Agents Chemother (2009) 1.04
West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function. J Virol (2009) 1.03
Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus. Antivir Chem Chemother (2007) 1.00
Construction of an infectious cDNA clone for a Brazilian prototype strain of dengue virus type 1: characterization of a temperature-sensitive mutation in NS1. Virology (2007) 0.99
West Nile virus genome amplification requires the functional activities of the proteasome. Virology (2008) 0.96
Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses. Adv Virus Res (2008) 0.96
Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methylguanosine. Antimicrob Agents Chemother (2011) 0.95
Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine (2003) 0.95
Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. J Virol (2014) 0.93
Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs. Virol J (2010) 0.93
A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes. Vaccine (2012) 0.93
Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies. Vaccine (2012) 0.93
Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex. Assay Drug Dev Technol (2012) 0.92
Identification of mutated cyclization sequences that permit efficient replication of West Nile virus genomes: use in safer propagation of a novel vaccine candidate. J Virol (2008) 0.92
A retro-lentiviral system for doxycycline-inducible gene expression and gene knockdown in cells with limited proliferative capacity. Mol Biol Rep (2009) 0.91
Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms. J Reprod Immunol (2007) 0.91
Immobilization of His-tagged proteins on nickel-chelating nanolipoprotein particles. Bioconjug Chem (2009) 0.88
Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection. Am J Trop Med Hyg (2010) 0.88
Antiviral activity of geneticin against dengue virus. Antiviral Res (2009) 0.88
The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB. Vaccine (2012) 0.88
Use of high-resolution confocal imaging of the vaginal epithelial microstructure to detect microbicide toxicity. J Infect Dis (2009) 0.87
RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters. Vaccine (2009) 0.87
Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen. Antiviral Res (2006) 0.87
Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2. J Virol (2008) 0.86
Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis. J Immunol (2011) 0.85
Estradiol improves genital herpes vaccine efficacy in mice. Vaccine (2009) 0.85
Benzalkonium chloride causes colposcopic changes and increased susceptibility to genital herpes infection in mice. Sex Transm Dis (2010) 0.85
Human RNA polymerase I-driven reverse genetics for influenza a virus in canine cells. J Virol (2010) 0.84
Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis. Bioconjug Chem (2010) 0.83
Optical coherence tomography for assessment of microbicide safety in a small animal model. J Biomed Opt (2013) 0.83
Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene. Vaccine (2011) 0.83
Long-term presence of virus-specific plasma cells in sensory ganglia and spinal cord following intravaginal inoculation of herpes simplex virus type 2. J Virol (2005) 0.82
Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model. Sex Transm Dis (2012) 0.82
Quantitative assessment of microbicide-induced injury in the ovine vaginal epithelium using confocal microendoscopy. BMC Infect Dis (2012) 0.82
Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine. Vaccine (2010) 0.82
Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection. J Virol Methods (2003) 0.82
Generation of a parvovirus B19 vaccine candidate. Vaccine (2013) 0.82
Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography. Am J Obstet Gynecol (2013) 0.81
Image-based noninvasive evaluation of colorectal mucosal injury in sheep after topical application of microbicides. Sex Transm Dis (2013) 0.81
In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models. Methods Mol Biol (2013) 0.80
Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments. Vaccine (2013) 0.80
Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling. Vaccine (2012) 0.80
Synergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1. PLoS Negl Trop Dis (2012) 0.80
Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02). J Virol Methods (2009) 0.79
Procedures for preventing transmission of foot-and-mouth disease virus (O/TAW/97) by people. Vet Microbiol (2004) 0.78
Development and utilization of a custom PCR array workflow: analysis of gene expression in mycoplasma genitalium and guinea pig (Cavia porcellus). Mol Biotechnol (2015) 0.78
Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity. Virology (2013) 0.77